Table 2.

Reported prevalences of GBV-C/HGV RNA in high risk groups in some published studies

Clinical group	Country	RNA+No. (%)	References
Haemodialysis	Egypt	79 (30)	(El-Zayadi et al. 1999)
	South Africa	70(24.3)	(Sathar et al. 1999b)
	Brazil	65(15.4)	(Lampe et al. 1997)
	China	79(54)	(Wang et al. 1997)
	France	61(57.5)	(Lamballerie et al. 1996)
	Japan	519(3.1)	(Masuko et al. 1996)
	Indonesia	58(55)	(Tsuda et al. 1996)
Haemophiliacs	Scotland	95(14)	(Jarvis et al. 1996)
	Europe	49(9)	(Linnen et al. 1996)
	France	92(17.4)	(Gerolami et al. 1997)
	Japan	63(24)	(Kinoshita et al. 1997)
	Nicaragua	45(38)	(Gonzales-Prez et al. 1997)
	South Africa	102(23.5)	(Castelling et al. 1998)
IVDUs	Greece	106(32.1)	(Anastassopoulou et al. 1998)
	US	27(4)	(Dille et al. 1997)
	US	102 (14.7)	(Gutierrez et al. 1997)
	Sweden	19(16)	(Shev et al. 1998)
	Europe	60(33.3)	(Linnen et al. 1996)
	Germany	99(38)	(Tacke et al. 1997a)
	Japan	49(12)	(Aikawa 1996)
Commercial blood donors	China	205(8)	(Roth et al. 1997)
	US	50(26)	(Dille et al. 1997)
	US	42(5)	(Pilot-Matias et al. 1996)
	US	711(13.1)	(Gutierrez et al. 1997)
Healthcare workers	Egypt	30(6,6)	(El-Zayadi et al. 1999)
Drug addicts	Nepal	72(44)	(Shrestha et al. 1997)
Prostitutes	UK	50(18)	(Scallan et al. 1998)
	China	140(21)	(Wu et al. 1997)
Homosexuals	UK	52(17)	(Scallan et al. 1998)
Homosexual & bisexual men	Germany	101(11)	(Schlueter et al. 1996)